NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268908. A total of 7 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $500,000 | – | 1,500 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 325,000 | $19,812,000 | 1.78% |
| SABBY MANAGEMENT, LLC | 592 | $3,609,000 | 0.46% |
| BOOTHBAY FUND MANAGEMENT, LLC | 221 | $1,347,000 | 0.13% |
| GROUP ONE TRADING, L.P. | 118,300 | $7,212,000 | 0.06% |
| SIMPLEX TRADING, LLC | 253 | $1,542,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 15,000 | $914,000 | 0.00% |